Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1393studies shown
Showing 1,376-1,393 of 1,393
CompletedNCT00606177

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolarity Experiencing a Manic or Mixed Episode

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
China, Japan, South Korea, Taiwan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity
CompletedNCT00606320

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolarity Experiencing a Manic or Mixed Episode

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
China, Japan, South Korea, Taiwan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity
CompletedNCT00606281

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolarity Experiencing a Manic or Mixed Episode

This study exists to compare options and see whether the medication Aripiprazole offers something meaningfully different. Researchers are trying to understand how people respond to the medication Aripiprazole in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
China, Japan, South Korea, Taiwan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity
CompletedNCT01447082

General Practice Research Database Seroquel XR Safety Study

This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 85 Years
Countries
Switzerland
Sponsor
AstraZeneca
Condition
Depression
CompletedNCT02050854

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolarity type I or Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what helps a medication treatment stay useful, realistic, and easier to follow over time.

BipolarityOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
CompletedNCT01795326

Physician Survey on Monitoring of Patients Treated With Quetiapine

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

DepressionOther
Countries
Global
Sponsor
AstraZeneca
Condition
Depression
CompletedNCT01793324

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.

DepressionOtherOver 18 Years
Countries
Global
Sponsor
AstraZeneca
Condition
Depression
CompletedNCT01821469

Functional Correlates of Bipolarity and Effects of the Psychoeducation. an fMRI Study

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand what psychoeducation, a guided learning and support program, can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Grenoble
Condition
Bipolarity
CompletedNCT00048802

Treatment and Outcome of Early Onset Bipolarity

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 10 Years to 18 Years
Countries
United States
Sponsor
Northwell Health
Condition
Bipolarity
WithdrawnNCT00359125

RU-486 in the Treatment of Depression in bipolarity

This study exists to learn from real-world information that can show how the medication RU-486 fits into care. Researchers are trying to understand whether the medication RU-486 can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity
TerminatedNCT04456868

Neurophysiological Markers in the Depressive Episode Characterized by Anhedonic Drug Resistance: Evaluation of Motor Skills and P300 Wave

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
University Hospital, Rouen
Condition
Depression
Not Yet RecruitingISRCTN18662002

Identifying and validating cognitive profiles in schizophrenia and bipolarity

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOtherFrom 18 Years to 100 Years
Countries
Spain
Sponsor
Centro de Investigación Biomédica en Red de Salud Mental
Condition
Bipolarity
Not Yet RecruitingISRCTN13022511

Identifying and validating cognitive profiles in schizophrenia and bipolarity: prospective phase of the PerfilesMICEmiEZ-TB study

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOtherFrom 18 Years to 100 Years
Countries
Spain
Sponsor
Centro de Investigación Biomédica en Red de Salud Mental
Condition
Bipolarity
TerminatedISRCTN93360820

Enhancing cognition in bipolarity

This public ISRCTN record appears to relate to bipolarity. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
Suffolk Mental Health Partnership NHS Trust (UK)
Condition
Bipolarity
TerminatedISRCTN45002938

A random controlled trial to compare the efficacy of a brief psycho-educational programme with standard care plus biblio-therapy for individuals with Bipolarity at high risk for relapse.

This public ISRCTN record appears to relate to bipolarity. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Bipolarity
Bipolarity | Clinical Trials | HopeStage Research